In particular, our focus on HCC risk as a result of PFESA-BP2 exposure, through the analysis of specific HCC pathways, revealed a previously unstudied association between PFESA-BP2 and HCC development. The gene discussed is IGFBP2; the disease is hepatocellular carcinoma.